Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 128

1.

Clinician-Delivered Teletherapy for Eating Disorders.

Sproch LE, Anderson KP.

Psychiatr Clin North Am. 2019 Jun;42(2):243-252. doi: 10.1016/j.psc.2019.01.008. Epub 2019 Apr 2. Review.

PMID:
31046926
2.

Artificial intelligence-augmented ECG assessment: The promise and the challenge.

Anderson KP.

J Cardiovasc Electrophysiol. 2019 May;30(5):675-678. doi: 10.1111/jce.13891. Epub 2019 Mar 11. No abstract available.

PMID:
30821036
3.

Cardiac Amyloidosis and the Risks of Cardioversion.

Anderson KP.

J Am Coll Cardiol. 2019 Feb 12;73(5):598-601. doi: 10.1016/j.jacc.2018.10.080. No abstract available.

PMID:
30732714
4.

Survey of procedural and resuscitation requirements for paediatricians working in a non-tertiary centre: Implications for training.

Hardy A, Fuller DG, Forrester M, Anderson KP, Cooper C, Jenner B, Marshall I, Sanderson C, Standish J, Worth J, Vuillermin P, McCloskey K.

J Paediatr Child Health. 2019 Apr;55(4):441-445. doi: 10.1111/jpc.14224. Epub 2018 Oct 9.

PMID:
30298956
5.

Left bundle branch block and the evolving role of QRS morphology in selection of patients for cardiac resynchronization.

Anderson KP.

J Interv Card Electrophysiol. 2018 Aug;52(3):353-374. doi: 10.1007/s10840-018-0426-z. Epub 2018 Aug 20. Review.

PMID:
30128803
6.

Optimization of a series of heterocycles as survival motor neuron gene transcription enhancers.

Choi S, Calder AN, Miller EH, Anderson KP, Fiejtek DK, Rietz A, Li H, Cherry JJ, Quist KM, Xing X, Glicksman MA, Cuny GD, Lorson CL, Androphy EA, Hodgetts KJ.

Bioorg Med Chem Lett. 2017 Dec 1;27(23):5144-5148. doi: 10.1016/j.bmcl.2017.10.066. Epub 2017 Oct 26.

7.

Per capita increase in hospital presentations and admissions among children since the 1990s.

Hardy A, Fuller DG, Forrester M, Anderson KP, Cooper C, Jenner B, Marshall I, Mccloskey K, Sanderson C, Standish J, Vuillermin P.

J Paediatr Child Health. 2016 Oct;52(10):935-938. doi: 10.1111/jpc.13232. Epub 2016 Jun 7.

PMID:
27272644
8.

A technology-based quality innovation to identify undiagnosed hypertension among active primary care patients.

Rakotz MK, Ewigman BG, Sarav M, Ross RE, Robicsek A, Konchak CW, Gavagan TF, Baker DW, Hyman DJ, Anderson KP, Masi CM.

Ann Fam Med. 2014 Jul;12(4):352-8. doi: 10.1370/afm.1665.

9.

Biological clocks and ventricular tachyarrhythmias.

Anderson KP.

J Am Coll Cardiol. 2014 Jun 24;63(24):2709-11. doi: 10.1016/j.jacc.2013.12.061. Epub 2014 Apr 16. No abstract available.

10.

Prevention of arrhythmic death in valvular heart disease: beware the implantable defibrillator paradox.

Anderson KP.

J Cardiovasc Electrophysiol. 2012 Dec;23(12):1333-5. doi: 10.1111/j.1540-8167.2012.02410.x. Epub 2012 Aug 7. No abstract available.

PMID:
22882158
11.

Ablation for atrial fibrillation: what are acceptable levels of experience, efficacy, and complications?

Anderson KP.

J Interv Card Electrophysiol. 2012 Aug;34(2):125-8. doi: 10.1007/s10840-012-9673-6. Epub 2012 Mar 9. No abstract available.

PMID:
22403043
12.

Programmed electrical stimulation for risk assessment in Brugada syndrome: time to change the guidelines?

Anderson KP.

J Am Coll Cardiol. 2012 Jan 3;59(1):46-8. doi: 10.1016/j.jacc.2011.09.039. No abstract available.

13.

Closing the gaps in atrial fibrillation ablation: the role of protected electrical connections.

Anderson KP.

J Cardiovasc Electrophysiol. 2011 Feb;22(2):160-2. doi: 10.1111/j.1540-8167.2010.01914.x. Epub 2010 Oct 6. No abstract available.

PMID:
21040097
14.

Development and usage of eXtension's HorseQuest: an online resource.

Greene EA, Griffin AS, Whittle J, Williams CA, Howard AB, Anderson KP.

J Anim Sci. 2010 Aug;88(8):2829-37. doi: 10.2527/jas.2010-2810. Epub 2010 Apr 9.

PMID:
20382882
15.

Health status assessment tools: natural components of cardiac resynchronization therapy?

Anderson KP.

Pacing Clin Electrophysiol. 2009 Oct;32(10):1257-8. doi: 10.1111/j.1540-8159.2009.02504.x. Epub 2009 Sep 1. No abstract available.

PMID:
19732356
16.

Estimates of implantable cardioverter-defibrillator complications: caveat emptor.

Anderson KP.

Circulation. 2009 Mar 3;119(8):1069-71. doi: 10.1161/CIRCULATIONAHA.108.841452. No abstract available.

PMID:
19255352
17.

The changing epidemiology of ventricular arrhythmias.

Anderson KP.

Cardiol Clin. 2008 Aug;26(3):321-33, v. doi: 10.1016/j.ccl.2008.03.007. Review.

PMID:
18538182
18.

Risk assessment for defibrillator therapy: Il Trittico.

Anderson KP.

J Am Coll Cardiol. 2007 Sep 18;50(12):1158-60. Epub 2007 Sep 4. No abstract available.

19.

Prevalence and mortality of patients with myocardial infarction and reduced left ventricular ejection fraction in a defined community: relation to the second multicenter automatic defibrillator implantation trial.

Sharma PP, Greenlee RT, Anderson KP, Chyou PH, Osorio HJ, Smith PN, Hayes JH, Vidaillet H.

J Interv Card Electrophysiol. 2007 Sep;19(3):157-64. Epub 2007 Sep 6.

PMID:
17805953
20.

Fibrinogen deficiency, but not plasminogen deficiency, increases mortality synergistically in combination with sickle hemoglobin SAD in transgenic mice.

Roszell NJ, Danton MJ, Jiang M, Witte D, Daugherty C, Grimes T, Girdler B, Anderson KP, Franco RS, Degen JL, Joiner CH.

Am J Hematol. 2007 Dec;82(12):1044-8.

21.

Patients with recently diagnosed nonischemic cardiomyopathy benefit from implantable cardioverter-defibrillators.

Kadish A, Schaechter A, Subacius H, Thattassery E, Sanders W, Anderson KP, Dyer A, Goldberger J, Levine J.

J Am Coll Cardiol. 2006 Jun 20;47(12):2477-82. Epub 2006 May 30.

22.

Cost-effectiveness of ICDs.

Anderson KP.

N Engl J Med. 2006 Jan 12;354(2):205-7; author reply 205-7. No abstract available.

PMID:
16407520
23.
24.

Multiple isoforms of the KC1 cotransporter are expressed in sickle and normal erythroid cells.

Crable SC, Hammond SM, Papes R, Rettig RK, Zhou GP, Gallagher PG, Joiner CH, Anderson KP.

Exp Hematol. 2005 Jun;33(6):624-31.

PMID:
15911086
25.
26.

Prophylactic defibrillator implantation in patients with nonischemic dilated cardiomyopathy.

Kadish A, Dyer A, Daubert JP, Quigg R, Estes NA, Anderson KP, Calkins H, Hoch D, Goldberger J, Shalaby A, Sanders WE, Schaechter A, Levine JH; Defibrillators in Non-Ischemic Cardiomyopathy Treatment Evaluation (DEFINITE) Investigators.

N Engl J Med. 2004 May 20;350(21):2151-8.

27.

Human potassium chloride cotransporter 1 (SLC12A4) promoter is regulated by AP-2 and contains a functional downstream promoter element.

Zhou GP, Wong C, Su R, Crable SC, Anderson KP, Gallagher PG.

Blood. 2004 Jun 1;103(11):4302-9. Epub 2004 Feb 19.

28.

Lipid-lowering therapy for prevention of ventricular tachyarrhythmias.

Anderson KP.

J Am Coll Cardiol. 2003 Jul 2;42(1):88-92. No abstract available.

29.

Sympathetic nervous system activity and ventricular tachyarrhythmias: recent advances.

Anderson KP.

Ann Noninvasive Electrocardiol. 2003 Jan;8(1):75-89. Review.

PMID:
12848817
30.

Asymmetric limb malformations in a new transgene insertional mutant, footless.

Bell SM, Schreiner CM, Hess KA, Anderson KP, Scott WJ.

Mech Dev. 2003 May;120(5):597-605.

31.
32.

Eating disorders and posttraumatic stress: phenomenological and treatment considerations using the two-factor model.

Lating JM, O'Reilly MA, Anderson KP.

Int J Emerg Ment Health. 2002 Spring;4(2):113-8.

PMID:
12166016
33.

A gene responsible for familial Wolff-Parkinson-White syndrome.

Anderson KP, Vidaillet HJ Jr, Josephson ME.

N Engl J Med. 2001 Oct 4;345(14):1063-4. No abstract available.

PMID:
11586962
34.

Transesophageal echocardiography to guide cardioversion in patients with atrial fibrillation.

Anderson KP.

N Engl J Med. 2001 Sep 13;345(11):837; author reply 838-9. No abstract available.

PMID:
11556310
35.

Modification of erythrocyte hydration in the treatment of sickle cell disease.

Zhou GP, Anderson KP, Joiner CH, Gallagher PG.

Blood Cells Mol Dis. 2001 Jan-Feb;27(1):65-8. Review. No abstract available.

PMID:
11358362
36.

Multidimensional rhythm disturbances as a precursor of sustained ventricular tachyarrhythmias.

Shusterman V, Aysin B, Anderson KP, Beigel A.

Circ Res. 2001 Apr 13;88(7):705-12.

PMID:
11304493
37.

Inhibition of human cytomegalovirus replication in a human retinal epithelial cell model by antisense oligonucleotides.

Detrick B, Nagineni CN, Grillone LR, Anderson KP, Henry SP, Hooks JJ.

Invest Ophthalmol Vis Sci. 2001 Jan;42(1):163-9.

PMID:
11133862
38.

Child sexual abuse and bulimic symptomatology: relevance of specific abuse variables.

Anderson KP, LaPorte DJ, Crawford S.

Child Abuse Negl. 2000 Nov;24(11):1495-502.

PMID:
11128180
39.

A comparison of T-wave alternans, signal averaged electrocardiography and programmed ventricular stimulation for arrhythmia risk stratification.

Gold MR, Bloomfield DM, Anderson KP, El-Sherif NE, Wilber DJ, Groh WJ, Estes NA 3rd, Kaufman ES, Greenberg ML, Rosenbaum DS.

J Am Coll Cardiol. 2000 Dec;36(7):2247-53.

40.

Enhancing the precision of ECG baseline correction: selective filtering and removal of residual error.

Shusterman V, Shah SI, Beigel A, Anderson KP.

Comput Biomed Res. 2000 Apr;33(2):144-60.

PMID:
10854121
41.

Defibrillators in nonischemic cardiomyopathy treatment evaluation.

Kadish A, Quigg R, Schaechter A, Anderson KP, Estes M, Levine J.

Pacing Clin Electrophysiol. 2000 Mar;23(3):338-43.

PMID:
10750134
42.

The GATA-E box-GATA motif in the EKLF promoter is required for in vivo expression.

Anderson KP, Crable SC, Lingrel JB.

Blood. 2000 Mar 1;95(5):1652-5.

43.

Changes in autonomic activity and ventricular repolarization.

Shusterman V, Beigel A, Shah SI, Aysin B, Weiss R, Gottipaty VK, Schwartzman D, Anderson KP.

J Electrocardiol. 1999;32 Suppl:185-92.

PMID:
10688324
44.

Dynamics of low-frequency R-R interval oscillations preceding spontaneous ventricular tachycardia.

Shusterman V, Aysin B, Weiss R, Brode S, Gottipaty V, Schwartzman D, Anderson KP.

Am Heart J. 2000 Jan;139(1 Pt 1):126-33.

PMID:
10618573
45.

Characterization of the lung Krüppel-like transcription factor gene and upstream regulatory elements.

Schrick JJ, Hughes MJ, Anderson KP, Croyle ML, Lingrel JB.

Gene. 1999 Aug 5;236(1):185-95.

PMID:
10433980
46.
47.

Inhibition of translation of hepatitis C virus RNA by 2-modified antisense oligonucleotides.

Brown-Driver V, Eto T, Lesnik E, Anderson KP, Hanecak RC.

Antisense Nucleic Acid Drug Dev. 1999 Apr;9(2):145-54.

PMID:
10355821
48.

A gene encoding an intestinal-enriched member of the Krüppel-like factor family expressed in intestinal epithelial cells.

Conkright MD, Wani MA, Anderson KP, Lingrel JB.

Nucleic Acids Res. 1999 Mar 1;27(5):1263-70.

49.

Antisense oligonucleotide inhibition of hepatitis C virus (HCV) gene expression in livers of mice infected with an HCV-vaccinia virus recombinant.

Zhang H, Hanecak R, Brown-Driver V, Azad R, Conklin B, Fox MC, Anderson KP.

Antimicrob Agents Chemother. 1999 Feb;43(2):347-53.

50.

Supplemental Content

Loading ...
Support Center